Know the methodology behind the report @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=2240
Reagents and Antibodies to Spearhead Growth of Histopathology Testing Equipment Market
Sales of consumables in the histopathology testing equipment market are estimated to be on an upswing in 2018, says the report. The growth in sales of consumables is largely attributed to the increasing demand for reagents and antibodies. Increasing use of reagents and kits in genomics, sequencing and diagnosis of chronic diseases remains instrumental in driving their sales worldwide. Fact.MR envisages that demand for reagents and antibodies is projected to expand at a significant rate of over 5.5 % in the coming years.
The growth of histopathology testing equipment market is also influenced by macroeconomic aspects such as rising geriatric population. Increasing geriatric population is closely associated with chronic disorders and diseases, which is expected to push the demand for histopathology testing equipment worldwide.
On this front, the report reveals that the demand for histopathology testing equipment across emerging economies in Asia Pacific such as China and India is projected to expand at a higher rate. According to United Nations, the number of aging population in India is expected to rise by 64 percent doing the 2015-2030 timeline, whereas China is likely to reflect a 71 percent increase in same time frame. This aspect continues to influence the use of histopathology testing equipment in a bid to reduce mortalities and facilitate health to the aged.
The demand for histopathology testing equipment for disease diagnosis applications is projected to expand at a stellar pace in the future. 2017 witnessed a positive spike in sales of histopathology testing equipment for disease diagnosis and the status quo is likely to continue in 2018 and ahead. Use of histopathology testing equipment in drug discovery is another field triggering the sales of histopathology testing equipment, in turn supporting growth of the overall histopathology testing equipment market, according to the report.
View Full Report with TOC @ https://www.factmr.com/report/2240/histopathology-testing-equipment-market
Clinical Autopsy and Histopathology – Another Histopathology Testing Equipment Sales Funnel for Manufacturers
Use of histopathology testing equipment in clinical autopsy has been influential in driving sales of histology instruments and kits. Clinical autopsy includes diagnosis of infectious diseases of different types including viruses, bacteria, helminths and protozoa. Majority of these are identified using histopathology using immunohistochemistry and stains that a vital part in clinical autopsy. Consequently, growing application in clinical autopsy is likely to impact sales of histopathology testing equipment across hospitals.
The report on histopathology testing equipment market includes assessment on key players involved in the manufacturing of histopathology testing equipment. Key aspects of histopathology testing equipment market players such as SWOT analysis, product portfolio analysis, innovations and developments, mergers and acquisitions, and key financials are included in the report. The histopathology testing equipment market report covers profiles of key players such as Thermo Fisher Scientific, Hoffman-La-Roche Ltd., and Leica Biosystems.
Companies in the histopathology testing equipment market are largely involved in product development. In 2018, Leica Biosystems has developed rotary microtome solutions that offer superior quality sectioning and improved user safety. The company has also launched next generation BOND-III ISH and IHC stainers. Likewise, Roche Diagnostics has launched VENTANA DP 200, a digital pathology device that connects with VENTANA iScan HT and iScan Coreo.
Companies in the histopathology testing equipment market are also involved in strategic alliances and acquisitions. For instance, Bio-Techne has signed an agreement to acquire Exosome Diagnostics with which Bio-Techne can enhance its position in the histopathology testing equipment space, particularly in the rapidly expanding non-invasive liquid biopsy.
In June 2018, Merck KGaA entered into an agreement with HistoCyte Laboratories Ltd., to sell products for in situ hybridization and immunohistochemistry. Under this agreement, Merck will deploy its sales expertise to market HistoCyte’s pathology slide controls in the US market and other geographies. This strategic collaboration will also enhance HistoCyte’s global reach in histopathology testing equipment space, particularly in the US market by leveraging Merck’s leadership.
Table of Content:
- Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
- Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
- Histopathology Testing Equipment Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
- Market Background
4.1. Market Dynamics
- Key Inclusions
5.1. Pricing Analysis
5.2. Key Developments
5.3. Product Life Cycle Analysis
5.4. Install Base Analysis, By Region
Grow Your Business From Expert Advice @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=2240
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
Read Industry News at- https://www.industrynewsanalysis.com/